Old Web
English
Sign In
Acemap
>
authorDetail
>
Yu Xiao
Yu Xiao
Guangxi Medical University
Molecular biology
Biology
Osteoclast
RANKL
Cancer research
4
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Scutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivo.
2019
Journal of Cellular Physiology
Fangsheng Fu
Siyuan Shao
Ziyi Wang
Fangming Song
Xixi Lin
Jiaxin Ding
Chen Li
Zuoxing Wu
Kai Li
Yu Xiao
Yiji Su
Jinmin Zhao
Qian Liu
Jiake Xu
Show All
Source
Cite
Save
Citations (6)
Diosmetin inhibits osteoclast formation and differentiation and prevents LPS‐induced osteolysis in mice
2019
Journal of Cellular Physiology
Siyuan Shao
Fangsheng Fu
Ziyi Wang
Fangming Song
Chen Li
Zuo xing Wu
Jiaxing Ding
Kai Li
Yu Xiao
Yiji Su
Xixi Lin
Guixin Yuan
Jinmin Zhao
Qian Liu
Jiake Xu
Show All
Source
Cite
Save
Citations (10)
Tiliroside is a new potential therapeutic drug for osteoporosis in mice: LI et al.
2019
Journal of Cellular Physiology
Kai Li
Yu Xiao
Ziyi Wang
Fangsheng Fu
Siyuan Shao
Fangming Song
Jinmin Zhao
Xixi Lin
Qian Liu
Jiake Xu
Show All
Source
Cite
Save
Citations (5)
Pectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL‐induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signaling
2019
Journal of Cellular Physiology
Yu Xiao
Kai Li
Ziyi Wang
Fangsheng Fu
Siyuan Shao
Fangming Song
Jinmin Zhao
Weiwei Chen
Qian Liu
Jiake Xu
Show All
Source
Cite
Save
Citations (14)
1